Oramed Pharmaceuticals
ORMP
#9015
Rank
C$0.17 B
Marketcap
C$4.47
Share price
-2.66%
Change (1 day)
43.62%
Change (1 year)

Earnings for Oramed Pharmaceuticals (ORMP)

Earnings in 2025 (TTM): C$80.13 Million

According to Oramed Pharmaceuticals's latest financial reports the company's current earnings are C$2 Million. In 2024 the company made an earning of -C$20.47 Million a decrease over its 2023 earnings that were of C$9.67 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Oramed Pharmaceuticals from 2006 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) C$80.13 M-491.62%
2024 -C$20.47 Million-311.47%
2023 C$9.67 M-119.45%
2022 -C$49.75 Million39.17%
2021 -C$35.75 Million73.93%
2020 -C$20.55 Million18.53%
2019 -C$17.34 Million-16.62%
2018 -C$20.8 Million38.32%
2017 -C$15.04 Million12.51%
2016 -C$13.37 Million25.01%
2015 -C$10.69 Million18.18%
2014 -C$9.05 Million39.72%
2013 -C$6.48 Million46.4%
2012 -C$4.43 Million128.32%
2011 -C$1.94 Million-51.47%
2010 -C$4 Million35.21%
2009 -C$2.96 Million
2007 -C$4.65 Million607.04%
2006 -C$0.66 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Novo Nordisk
NVO
C$28.04 B 35,325.54%๐Ÿ‡ฉ๐Ÿ‡ฐ Denmark
Sanofi
SNY
C$12.35 B 15,508.83%๐Ÿ‡ซ๐Ÿ‡ท France
Ultragenyx Pharmaceutical
RARE
-C$0.71 Billion-989.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Lexicon Pharmaceuticals
LXRX
-C$93.14 Million-217.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Compugen
CGEN
-C$37.43 Million-147.27%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel